Goals and Strategies for Prevention of Preterm Birth: An Obstetric Perspective

Pediatric Clinics of North America

Volumn 56, Issue 3, 2009, Pages 537-563

  Lang, Christopher T ^a,b   Iams, Jay D ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b Mount Carmel St Ann's Hospital   (United States)

Author keywords

Indicated preterm birth; Neonatal outcomes; Perinatal mortality; Prevention; Spontaneous preterm birth

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ASCORBIC ACID; AZITHROMYCIN; CALCIUM; CORTICOSTEROID; ERYTHROMYCIN; METRONIDAZOLE; PLACEBO; PROGESTERONE; ANTIINFECTIVE AGENT;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; CESAREAN SECTION; CLINICAL TRIAL; DENTAL CARE; DIET SUPPLEMENTATION; EARLY DIAGNOSIS; FETUS MORTALITY; GESTATIONAL AGE; HUMAN; INFANT MORTALITY; LOW DRUG DOSE; MATERNAL MORBIDITY; MATERNAL MORTALITY; PERINATAL MORTALITY; PERIODONTAL DISEASE; PREECLAMPSIA; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PREMATURITY; PRENATAL CARE; PRENATAL SCREENING; PRIMARY PREVENTION; REVIEW; RISK BENEFIT ANALYSIS; SECONDARY PREVENTION; SMOKING CESSATION; SOCIAL SUPPORT; STILLBIRTH; TRICHOMONAS VAGINALIS; UTERINE CERVIX CERCLAGE; VAGINITIS; BED REST; FEMALE; OBSTETRICS; PREGNANCY;

ANTI-BACTERIAL AGENTS; BED REST; CERCLAGE, CERVICAL; DIETARY SUPPLEMENTS; FEMALE; HUMANS; OBSTETRICS; PERIODONTAL DISEASES; PREGNANCY; PREMATURE BIRTH; PRENATAL CARE; PROGESTERONE;

EID: 67649105277     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcl.2009.03.006     Document Type: Review

References (223)

1. Callaghan W.M., MacDorman M.F., Rasmussen S.A., et al. The contribution of preterm birth to infant mortality in the United States. Pediatrics 118 (2006) 1566-1573
2. Martin J.A., Hamilton B.E., Sutton P.D., et al. Births: final data for 2004. Natl Vital Stat Rep 55 (2006) 1-101
3. Romero R., Espinoza J., Mazor M., et al. The preterm parturition syndrome. In: Critchley H., Bennett P., and Thornton S. (Eds). Preterm birth (2004), RCOG Press, London 28-60
4. Goldenberg R.L., Culhane J.F., Iams J.D., et al. Epidemiology and causes of preterm birth. Lancet 371 (2007) 73-82
5. Lockwood C.J., and Iams J.D. Preterm labor and delivery. In: Berens P.D., Bukowski R.K., and Clark S.L. (Eds). Precis: obstetrics (2005), ACOG, Danvers (MA) p. 59
6. Meis P.J., Michielutte R., Peters T.J., et al. Factors associated with preterm birth in Cardiff Wales: II. Indicated and spontaneous preterm birth. Am J Obstet Gynecol 173 (1995) 597-602
7. American College of Obstetricians and Gynecologists. Management of preterm labor. ACOG Practice Bulletin number 43. Obstet Gynecol 101 (2003) 1039-1047
8. Murphy K.E., Hannah M.E., WIllan A.R., et al. Multiple courses of antenatal corticosteroids for preterm birth (MACS): a randomised trial. Lancet 372 (2008) 2143-2151
9. Wapner R.J., Sorokin Y., Thom E.A., et al. Single vs. weekly courses of antenatal corticosteroids: evaluation of safety and efficacy. Am J Obstet Gynecol 195 (2006) 633-642
10. Wapner R.J., Sorokin Y., Mele L., et al. Long term outcomes after repeat doses of antenatal corticosteroids. N Engl J Med 357 (2007) 1190-1198
11. Mercer B.M., Miodovnik M., Thurnau G.R., et al. Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes. A randomized controlled trial. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. JAMA 278 (1997) 989-995
12. Kenyon S.L., Taylor D.J., Tarnow-Mordi W., and for the ORACLE Collaborative Group. Broad spectrum antibiotics for preterm, prelabour rupture of the fetal membranes: the ORACLE I randomised trial. Lancet 357 (2001) 979-988
13. Stoll B.J., Hansen N., Fanaroff A.A., et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med 347 (2002) 240-247
14. Kenyon S.L., Taylor D.J., Tarnow-Mordi W., and for the ORACLE Collaborative Group. Broad spectrum antibiotics for spontaneous preterm labour: the ORACLE II randomised trial. Lancet 357 (2001) 989-994
15. Kenyon S.L., Pike K., Jones D.R., et al. Childhood outcomes after prescription of antibiotics to pregnant women with preterm rupture of the membranes: 7-year follow-up of the ORACLE I trial. Lancet 372 (2008) 1310-1318
16. Kenyon S.L., Pike K., Jones D.R., et al. Childhood outcomes after prescription of antibiotics to pregnant women with spontaneous preterm labour: 7-year follow-up of the ORACLE II trial. Lancet 372 (2008) 1319-1327
17. Bedford Russell A.R., and Steer P.J. Antibiotics in preterm labour-the ORACLE speaks. Lancet 372 (2008) 1276-1278
18. Romero R., Espinoza J., Kusanovic J.P., et al. The preterm parturition syndrome. BJOG 113 Suppl 3 (2006) 118-135
19. Jobe A.H. Glucocorticoids, inflammation, and the perinatal lung. Semin Neonatol 6 (2001) 331-342
20. Dammann O., and Leviton A. Inflammation, brain damage, and visual dysfunction in preterm infants. Semin Fetal Neonatal Med 11 (2006) 363-368
21. Norton M.E., Merrill J., Cooper B.A., et al. Neonatal complications after the administration of indomethacin for preterm labor. N Engl J Med 329 (1993) 1602-1607
22. Vermillion S.T., and Newman R.B. Recent indomethacin tocolysis is not associated with neonatal complications in preterm infants. Am J Obstet Gynecol 181 (1999) 1083-1086
23. Loe S.M., Sanchez-Ramos L., and Kaunitz A.M. Assessing the neonatal safety of indomethacin tocolysis: a systematic review with meta-analysis. Obstet Gynecol 106 (2005) 173-179
24. Suarez R.D., Grobman W.A., and Parilla B.V. Indomethacin tocolysis and intraventricular hemorrhage. Obstet Gynecol 97 (2001) 921-925
25. Klebanoff M.A., Carey J.C., Hauth J.C., et al. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N Engl J Med 345 (2001) 487-493
26. Andrews W.W., Sibai B.M., Thom E.A., et al. Randomized clinical trial of metronidazole plus erythromycin to prevent spontaneous preterm delivery in fetal fibronectin-positive women. Obstet Gynecol 101 (2003) 847-855
27. Shennan A., Crawshaw S., Briley A., et al. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study. BJOG 113 (2006) 65-74
28. da Fonseca E.B., Bittar R.E., Carvalho M.H., et al. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol 188 (2003) 419-424
29. Meis P.J., Klebanoff M., Thom E., et al. Prevention of recurrent preterm delivery by 17-alpha-hydroxyprogesterone caproate. N Engl J Med 348 (2003) 2379-2385
30. Fonseca E.B., Celik E., Parra M., et al. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med 357 (2007) 462-469
31. Elovitz M.A., and Mrinalini C. The use of progestational agents for preterm birth: lessons from a mouse model. Am J Obstet Gynecol 195 (2006) 1004-1010
32. Consequences of preterm birth. In: Behrman R.E., and Stith Butler A. (Eds). Preterm birth: causes, consequences, and prevention (Institute of Medicine) (2007), National Academies Press, Washington, DC 311-345
33. Kung H.C., Hoyert D.L., Xu J.Q., et al. Deaths: final data for 2005. Natl Vital Stat Rep 56 (2008) 1-120
34. MacDorman M.F., and Mathews T.J. Recent trends in infant mortality in the United States. NCHS data brief, no 9 (2008), National Center for Health Statistics, Hyattsville (MD)
35. Martin J.A., Hamilton B.E., Sutton P.D., et al. Births: final data for 2005. Natl Vital Stat Rep 56 (2007) 1-103
36. CDC. Preliminary births for 2004. Available at:. http://www.cdc.gov/nchs/products/pubs/pubd/hestats/prelim_births/prelim_births04.htm
37. Martin J.A., Hamilton B.E., Ventura S.J., et al. Births: final data for 2001. Natl Vital Stat Rep 51 (2002) 1-102
38. Ananth C.V., and Vintzileos A.M. Medically indicated preterm birth: recognizing the importance of the problem. Clin Perinatol 35 (2008) 53-67
39. Fuchs K., and Gyamfi C. The influence of obstetric practices on late prematurity. Clin Perinatol 35 (2008) 343-360
40. Alexander G.R., De Caunes F., Hulsey T.C., et al. Validity of postnatal assessments of gestational age: a comparison of the method of Ballard, et al and early ultrasonography. Am J Obstet Gynecol 166 (1992) 891-895
41. Savitz D.A., Terry Jr. J.W., Dole N., et al. Comparison of pregnancy dating by last menstrual period, ultrasound scanning, and their combination. Am J Obstet Gynecol 187 (2002) 1660-1666
42. Yang C.Y., Kramer M.S., Platt R.W., et al. How does early ultrasound scan estimation of gestational age lead to higher rates of preterm birth?. Am J Obstet Gynecol 186 (2002) 433-437
43. Davidoff M.J., Dias T., Damus K., et al. Changes in gestational age distribution among US singleton births: impact on rates of later preterm birth, 1992 to 2002. Semin Perinatol 30 (2006) 8-15
44. MacDorman M.F., Munson M.L., Kirmeyer S., et al. Fetal and perinatal mortality, United States, 2004. Natl Vital Stat Rep 56 (2007) 1-19
45. Engle W.A., and Kominiarek M.A. Late preterm infants, early term infants, and timing of elective deliveries. Clin Perinatol 35 (2008) 325-341
46. Jain T., Missmer S.A., and Hornstein M.D. Trends in embryo-transfer practice and in outcomes of the use of assisted reproductive technology in the United States. N Engl J Med 350 (2004) 1639-1645
47. Di Renzo G.C., Moscioni P., Perazzi A., et al. Social policies in relation to employment and pregnancy in European countries. Prenat Neonatal Med 3 (1998) 147-156
48. Saurel-Cubizolles M.J., Zeitlin J., Lelong N., et al., for the Europop Group. Employment, working conditions, and preterm birth: results from the Europop case-control survey. J Epidemiol Community Health 58 (2004) 395-401
49. Launer L.J., Villar J., Kestler E., et al. The effect of maternal work on fetal growth and duration of pregnancy: a prospective study. BJOG 97 (1990) 62-70
50. Pompeii L.A., Savitz D.A., Evenson K.R., et al. Physical exertion at work and the risk of preterm delivery and small-for-gestational-age birth. Obstet Gynecol 106 (2005) 1279-1288
51. Czeizel A.E., Dudas I., and Metnecki J. Pregnancy outcomes in a randomized controlled trial of periconceptional multivitamin supplementation. Final report. Arch Gynecol Obstet 255 (1994) 131-139
52. Burguet A., Kaminski M., Abraham-Lerat L., et al. The complex relationship between smoking in pregnancy and very preterm delivery: results of the Epipage study. BJOG 111 (2004) 258-265
53. Shah N.R., and Bracken M.B. A systematic review and meta-analysis of prospective studies in the association between maternal cigarette smoking and preterm delivery. Am J Obstet Gynecol 182 (2000) 465-472
54. Salihu H.M., Pierre-Louis B.J., and Alexander G.R. Levels of excess infant deaths attributable to maternal smoking during pregnancy in the United States. Matern Child Health J 7 (2003) 219-227
55. Vahratian A., Siega-Riz A.M., Savitz D.A., et al. Multivitamin use and the risk of preterm birth. Am J Epidemiol 160 (2004) 886-892
56. Kramer M.S., and Kakuma R. Energy and protein intake in pregnancy. Cochrane Database Syst Rev 4 (2003) CD000032
57. Levine R.J., Hauth J.C., Curet L.B., et al. Trial of calcium to prevent preeclampsia. N Engl J Med 337 (1997) 69-76
58. Hofmeyr G.J., Atallah A.N., and Duley L. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev 3 (2006) CD001059
59. Rumbold A.R., Crowther C.A., Haslam R.R., et al. Vitamins C and E and the risks of preeclampsia and perinatal complications. N Engl J Med 354 (2006) 1796-1806
60. Smuts C.M., Huang M., Mundy D., et al. A randomized trial of docosahexanoic acid supplementation during the third trimester of pregnancy. Obstet Gynecol 101 (2003) 469-479
61. Ricketts S.A., Murray E.K., and Schwalberg R. Reducing low birth weight by resolving risks: results from Colorado's prenatal plus program. Am J Public Health 95 (2005) 1952-1957
62. Lumley J., Oliver S.S., Chamberlain C., et al. Interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev 4 (2004) CD001055
63. Healy A.J., Malone F.D., Sullivan L.M., et al. Early access to prenatal care: implications for racial disparity in perinatal mortality. Obstet Gynecol 107 (2006) 625-631
64. Papiernik E., Bouyer J., Dreyfus J., et al. Prevention of preterm births: a perinatal study in Haguenau, France. Pediatrics 76 (1985) 154-158
65. Offenbacher S., Boggess K.A., Murtha A.P., et al. Progressive periodontal disease and risk of very preterm delivery. Obstet Gynecol 107 (2006) 29-36
66. Stamilio D.M., Chang J.J., and Macones G.A. Periodontal disease and preterm birth: do the data have enough teeth to recommend screening and preventative treatment?. Am J Obstet Gynecol 196 (2007) 93-94
67. Pretorius C., Jagatt A., and Lamont R.F. The relationship between periodontal disease, bacterial vaginosis, and preterm birth. J Perinat Med 35 (2007) 93-99
68. Moore S., Ide M., Coward P.Y., et al. A prospective study to investigate the relationship between periodontal diseases and adverse pregnancy outcome. Br Dent J 197 (2004) 251-258
69. Michalowicz B.S., Hodges J.S., Di Angelis A.J., et al. Treatment of periodontal disease and the risk of preterm birth. N Engl J Med 355 (2006) 1885-1894
70. Vergnes J.-N., and Sixou M. Preterm low birthweight and paternal periodontal status: a meta-analysis. Am J Obstet Gynecol 196 (2007) 135 e1-7
71. Elder H.A., Santamarina B.A., Smith S., et al. The natural history of asymptomatic bacteriuria during pregnancy: the effect of tetracycline on the clinical course and the outcome of pregnancy. Am J Obstet Gynecol 111 (1971) 441-446
72. Romero R., Oyarzun E., Mazor M., et al. Meta-analysis of the relationship between asymptomatic bacteriuria and preterm delivery/low birth weight. Obstet Gynecol 73 (1989) 576-582
73. Goldenberg R.L., Iams J.D., Mercer B.M., et al. The preterm prediction study: the value of new vs. standard risk factors in predicting early and all spontaneous preterm births. NICHD MFMU Network. Am J Public Health 88 (1998) 233-238
74. Eschenbach D.A., Nugent R.P., Rao V.R., et al. A randomized placebo-controlled trial of erythromycin for the treatment of U. urealyticum to prevent premature delivery. Am J Obstet Gynecol 164 (1991) 734-742
75. Klebanoff M.A., Regan J.A., Rao V.R., et al. Outcome of the vaginal infections and prematurity study: results of a clinical trial of erythromycin among pregnant women colonized with group B streptococci. Am J Obstet Gynecol 172 (1995) 1540-1545
76. Kigozi G.G., Brahmbhatt H., Wabwire-Mangen F., et al. Treatment of trichomonas in pregnancy. Am J Obstet Gynecol 189 (2003) 1398-1400
77. Riggs M.A., and Klebanoff M.A. Treatment of vaginal infections to prevent preterm birth: a meta-analysis. Clin Obstet Gynecol 47 (2004) 796-807
78. McDonald H.M., Brocklehurst P., and Gordon A. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev 1 (2007) CD000262
79. ACOG Practice Bulletin 31. Assessment of risk factors for preterm birth. Obstet Gynecol 98 (2001) 708-716
80. CDC. Sexually transmitted diseases treatment guidelines 2006. Available at: http://www.cdc.gov/std/treatment/.
81. Leveno K.J., Cox K., and Roark M.L. Cervical dilatation and prematurity revisited. Obstet Gynecol 68 (1986) 434-435
82. Andersen H.F., Nugent C.E., Wanty S.D., et al. Prediction of risk for preterm delivery by ultrasonographic measurement of cervical length. Am J Obstet Gynecol 163 (1990) 859-867
83. Iams J.D., Goldenberg R.L., Meis P.J., et al. The length of the cervix and the risk of spontaneous preterm delivery. N Engl J Med 334 (1996) 567-573
84. Taipale P., and Hiilesmaa V. Sonographic measurement of uterine cervix at 18-22 weeks' gestation and the risk of preterm delivery. Obstet Gynecol 92 (1998) 902-907
85. Heath V.C., Southall T.R., Souka A.P., et al. Cervical length at 23 weeks of gestation: prediction of spontaneous preterm delivery. Ultrasound Obstet Gynecol 12 (1998) 312-317
86. Matijevic R., Grgic O., and Vasili O. Is sonographic assessment of cervical length better than digital examination in screening for preterm delivery in a low-risk population?. Acta Obstet Gynecol Scand 85 (2006) 1342-1347
87. To M.S., Alfirevic Z., Hauth V.C., et al. Cervical cerclage for prevention of preterm delivery in women with short cervix: randomized controlled trial. Lancet 363 (2004) 1849-1853
88. Berghella V., Odibo A., To M.S., et al. Cerclage for short cervix on ultrasonography; meta-analysis of trials using individual patient data. Obstet Gynecol 106 (2005) 181-189
89. Iams J.D., Goldenberg R.L., Mercer B.M., et al. The Preterm Prediction Study: can low risk women destined for spontaneous preterm birth be identified?. Am J Obstet Gynecol 184 (2001) 652-655
90. Goldenberg R.L., Iams J.D., Mercer B.M., et al. The Preterm Prediction Study: toward a multiple-marker test for spontaneous preterm birth. Am J Obstet Gynecol 185 (2001) 643-651
91. Patton P.E., Novy M.J., Lee D.M., et al. The diagnosis and reproductive outcome after surgical treatment of the complete septate uterus, duplicated cervix and vaginal septum. Am J Obstet Gynecol 190 (2004) 1669-1675
92. Lumley J., and Donohue L. Aiming to increase birth weight: a randomized trial of pre-pregnancy information, advice and counseling in inner-urban Melbourne. BMC Public Health 6 (2006) 299
93. Andrews W.W., Goldenberg R.L., Hauth J.C., et al. Inter-conceptional antibiotics to prevent spontaneous preterm birth: a randomized trial. Am J Obstet Gynecol 194 (2006) 617-623
94. Espinoza J., Erez O., and Romero R. Preconceptional antibiotic treatment to prevent preterm birth in women with a previous preterm delivery. Am J Obstet Gynecol 194 (2006) 630-637
95. Sibai B.M., Caritis S.N., Thom E., et al. Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. N Engl J Med 329 (1993) 1213-1218
96. Caritis S., Sibai B., Hauth J., et al. Low-dose aspirin to prevent preeclampsia in women at high risk. N Engl J Med 338 (1998) 701-705
97. Poston L., Briley A.L., Seed P.T., et al., Vitamins in Pre-eclampsia (VIP) Trial Consortium. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomized placebo-controlled trial. Lancet 367 (2006) 1145-1154
98. Olsen S.F., Sorenson J.D., Secher N.J., et al. Randomized controlled trial of effect of fish-oil supplementation on pregnancy duration. Lancet 339 (1992) 1003-1007
99. Olsen S.F., Secher N.J., Tabor A., et al. Randomized controlled trials of fish oil supplementation in high risk pregnancies. Fish Oil Trials in Pregnancy (FOTIP) Team. BJOG 107 (2000) 382-395
100. Duley L., Henderson-Smart D.J., Meher S., et al. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2 (2007) CD004659
101. Rumbold A., Duley L., Crowther C., et al. Antioxidants for preventing pre-eclampsia. Cochrane Database Syst Rev 4 (2005) CD004227
102. Goldenberg R.L., Cliver S.P., Bronstein J., et al. Bed rest in pregnancy. Obstet Gynecol 84 (1994) 131-136
103. Sosa C., Althabe F., Belizan J., et al. Bed rest in singleton pregnancies for preventing preterm birth. Cochrane Database Syst Rev 1 (2004) CD003581
104. Yost N.P., Owen J., Berghella V., et al. Effect of coitus on recurrent preterm birth. Obstet Gynecol 107 (2006) 793-797
105. Olds D.L., Henderson Jr. C.R., Tatelbaum R., et al. Improving delivery of prenatal care and outcomes of pregnancy: a randomized trial of nurse home visitation. Pediatrics 77 (1986) 16-28
106. Quinlivan J.A., and Evans S.F. Teenage antenatal clinics may reduce the rate of preterm birth: a prospective study. BJOG 111 (2004) 571-578
107. Bryce R.L., Stanley F.J., and Garner R.B. Randomized controlled trial of antenatal social support to prevent preterm birth. BJOG 98 (1991) 1001-1008
108. Villar J., Farnot U., Barros F., et al. A randomized trial of psychosocial support during high risk pregnancies. N Engl J Med 327 (1992) 1266-1271
109. Collaborative Working Group on Prematurity. Multicenter randomized controlled trial of a preterm birth prevention trial. Am J Obstet Gynecol 169 (1993) 352-366
110. Kitzman H., Olds D.L., Henderson Jr. C.R., et al. Effect of prenatal and home visitation by nurses on pregnancy outcomes, childhood injuries, and repeated childbearing. A randomized study. JAMA 278 (1997) 644-652
111. Klerman L.V., Ramey S.L., Goldenberg R.L., et al. A randomized trial of augmented prenatal care for multiple-risk, Medicaid-eligible African American women. Am J Public Health 91 (2001) 105-111
112. Dyson D.C., Danbe K.H., Bamber J.A., et al. Monitoring women at risk for preterm birth. N Engl J Med 338 (1998) 15-19
113. Hodnett E.D., and Fredericks S. Support during pregnancy for women at increased risk of low birth weight babies. Cochrane Database Syst Rev 3 (2003) CD000198
114. Lamont R.F. Can antibiotics prevent preterm birth-the pro and con debate. BJOG 112 Suppl 1 (2005) 67-73
115. Goldenberg R.L., Mwatha A., Read J.S., et al. The HPTN 024 study: the efficacy of antibiotics to prevent chorioamnionitis and preterm birth. Am J Obstet Gynecol 194 (2006) 650-661
116. Ugwumadu A., Reid F., Hay P., et al. Oral clindamycin and histologic chorioamnionitis in women with abnormal vaginal flora. Obstet Gynecol 107 (2006) 863-868
117. Keirse M.J. Progestogen administration in pregnancy may prevent preterm delivery. BJOG 97 (1990) 149-154
118. Sanchez-Ramos L., Kaunitz A.M., and Delke I. Progestational agents to prevent preterm birth: a meta-analysis of randomized controlled trials. Obstet Gynecol 10 (2005) 273-279
119. Dodd J.M., Flenady V., Cincotta R., et al. Prenatal administration of progesterone for preventing preterm birth. Cochrane Database Syst Rev 1 (2006) CD004947
120. Mackenzie R., Walker M., Armson A., et al. Progesterone for the prevention of preterm birth among women at increased risk. A systematic review and meta-analysis of randomized controlled trials. Am J Obstet Gynecol 194 (2006) 1234-1242
121. Pouse D.J., Caritis S.N., Peaceman A.M., et al. A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. N Engl J Med 357 (2007) 454-461
122. Althusius S.M., Dekker G.A., Hummel P., et al. Final results of the Cervical Incompetence Prevention Randomized Cerclage Trial (CIPRACT): therapeutic cerclage with bed rest versus bed rest alone. Am J Obstet Gynecol 185 (2001) 1106-1112
123. Rust O.A., Atlas R.O., Reed J., et al. Revisiting the short cervix detected by transvaginal ultrasound in the second trimester: why cerclage therapy may not help. Am J Obstet Gynecol 185 (2001) 1098-1105
124. Guzman E.R., Forster J.K., Vintzileos A.M., et al. Pregnancy outcomes in women treated with elective versus ultrasound-indicated cervical cerclage. Ultrasound Obstet Gynecol 12 (1998) 323-327
125. Hassan S.S., Romero R., Maymon E., et al. Does cervical cerclage prevent preterm delivery in patients with a short cervix?. Am J Obstet Gynecol 184 (2001) 1325-1329
126. Berghella V., Haas S., Chervoneva I., et al. Patients with prior second-trimester loss: prophylactic cerclage or serial transvaginal sonograms?. Am J Obstet Gynecol 187 (2002) 747-751
127. To M.S., Palaniappan V., Skentou C., et al. Elective cerclage vs. ultrasound-indicated cerclage in high-risk pregnancies. Ultrasound Obstet Gynecol 19 (2002) 475-477
128. Kurup M., and Goldkrand J.W. Cervical incompetence: elective, emergent, or urgent cerclage. Am J Obstet Gynecol 181 (1999) 240-246
129. Guzman E.R., and Ananth C.V. Cervical length and spontaneous prematurity: laying the foundation for future interventional randomized trials for the short cervix. Ultrasound Obstet Gynecol 18 (2001) 195-199
130. Althusius S.M., Dekker G.A., van Geijn H.P., et al. Cervical incompetence prevention randomized cerclage trial (CIPRACT): study design and preliminary results. Am J Obstet Gynecol 183 (2000) 823-829
131. Althuisius S., Dekker G., Hummel P., et al. Cervical Incompetence Prevention Randomized Cerclage Trial (CIPRACT): effect of therapeutic cerclage with bed rest vs. bed rest only on cervical length. Ultrasound Obstet Gynecol 20 (2002) 163-167
132. Berghella V., Odibo A.O., and Tolosa J.E. Cerclage for prevention of preterm birth in women with a short cervix found on transvaginal ultrasound examination: a randomized trial. Am J Obstet Gynecol 191 (2004) 1311-1317
133. Lazar P., Gueguen S., Dreyfus J., et al. Multicentred controlled trial of cervical cerclage in women at moderate risk of preterm delivery. BJOG 91 (1984) 731-735
134. Rush R.W., Isaacs S., McPherson K., et al. A randomized controlled trial of cervical cerclage in women at high risk of spontaneous preterm delivery. BJOG 91 (1984) 724-730
135. Final Report of the Medical Research Council/Royal College of Obstetricians and Gynaecologists multicentre randomized trial of cervical cerclage. MRC/RCOG Working Party on Cervical Cerclage. BJOG 100 (1993) 516-523
136. Althusius S.M., Dekker G.A., Hummel P., et al. Cervical Incompetence Prevention Randomized Cerclage Trial: emergency cerclage with bed rest versus bed rest alone. Am J Obstet Gynecol 189 (2003) 907-910
137. Berghella V., Daly S.F., Tolosa J.E., et al. Prediction of preterm delivery with transvaginal ultrasonography of the cervix in patients with high-risk pregnancies: does cerclage prevent prematurity?. Am J Obstet Gynecol 181 (1999) 809-815
138. Groom K.M., Bennett P.R., Golara M., et al. Elective cervical cerclage versus serial ultrasound surveillance of cervical length in a population at high risk for preterm delivery. Eur J Obstet Gynecol Reprod Biol 112 (2004) 158-161
139. Higgins S.P., Kornman L.H., Bell R.J., et al. Cervical surveillance as an alternative to elective cervical cerclage for pregnancy management of suspected cervical incompetence. Aust N Z J Obstet Gynaecol 44 (2004) 228-232
140. Sakai M., Shiozaki A., Tabata A., et al. Evaluation of effectiveness of prophylactic cerclage of a short cervix according to interleukin-8 in cervical mucus. Am J Obstet Gynecol 194 (2006) 14-19
141. Mueller-Heubach E., Reddick D., Barnett B., et al. Preterm birth prevention: evaluation of a prospective controlled randomized trial. Am J Obstet Gynecol 160 (1989) 1172-1178
142. Hueston W.A., Knox M.A., Eilers G., et al. The effectiveness of preterm birth educational programs for high-risk women. Obstet Gynecol 86 (1995) 705-712
143. A multicenter randomized controlled trial of home uterine monitoring: active versus sham device. The Collaborative Home Uterine Monitoring Study (CHUMS) Group. Am J Obstet Gynecol 173 (1995) 1120-1127
144. Towers C.V., Bonebrake R., Padilla G., et al. The effect of transport on the rate of severe intraventricular hemorrhage in very low birth weight infants. Obstet Gynecol 95 (2000) 291-295
145. Smith G.N., Walker M.C., Ohlsson A., et al., Canadian Preterm Labour Nitroglycerin Trial Group. Randomized double blind placebo controlled trial of transdermal nitroglycerin for preterm labor. Am J Obstet Gynecol 196 (2007) 37 e1-8
146. King J.F., Flenady V.J., Papatsonis D.N.M., et al. Calcium channel blockers for inhibiting preterm labour. Cochrane Database Syst Rev 1 (2003) CD002255
147. Papatsonis D., Flenady V., Cole S., et al. Oxytocin receptor antagonists for inhibiting preterm labour. Cochrane Database Syst Rev 3 (2005) CD004452
148. Anotayanonth S., Subhedar N.V., Neilson J.P., et al. Betamimetics for inhibiting preterm labour. Cochrane Database Syst Rev 4 (2004) CD004352
149. Crowther C.A., Hiller J.E., and Doyle L.W. Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database Syst Rev 4 (2002) CD001060
150. Mittendorf R., Covert R., Boman J., et al. Is tocolytic magnesium sulphate associated with increased total paediatric mortality?. Lancet 350 (1997) 1517-1518
151. King J., Flenady V., Cole S., et al. Cyclo-oxygenase (COX) inhibitors for treating preterm labour. Cochrane Database Syst Rev 2 (2005) CD001992
152. Roberts D., and Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 3 (2006) CD004454
153. Schrag S., Gorwitz R., Fultz-Butts K., et al. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 51 (2002) 1-22
154. Nanda K., Cook L.A., Gallo M.F., et al. Terbutaline pump maintenance therapy after threatened preterm labor for preventing preterm birth. Cochrane Database Syst Rev 4 (2002) CD003933
155. Dodd J.M., Crowther C.A., Dare M.R., et al. Oral betamimetics for maintenance therapy after threatened preterm labour. Cochrane Database Syst Rev 1 (2006) CD003927
156. Grant A., Penn Z.J., and Steer P.J. Elective or selective caesarean delivery of the small baby? A systematic review of the controlled trials. BJOG 103 (1996) 1197-1200
157. Deulofeut R., Sola A., Lee B., et al. The impact of vaginal delivery in premature infants weighing less than 1251 grams. Obstet Gynecol 105 (2005) 525-531
158. Riskin A., Riksin-Mashiah S., Lusky A., et al. The relationship between delivery mode and mortality in very low birthweight singleton vertex-presenting infants. BJOG 111 (2004) 1365-1371
159. Iams J.D., Romero R., Culhane J.F., et al. Primary, secondary, and tertiary interventions to reduce the morbidity and mortality of preterm birth. Lancet 371 (2008) 164-175
160. Papiernik E. Preventing preterm birth-is it really impossible? A comment on the IOM report on preterm birth. Matern Child Health J 11 (2007) 407-410
161. Hall R.T. Prevention of premature birth: do pediatricians have a role?. Pediatrics 105 (2000) 1137-1140
162. Tyson J., Guzick D., Rosenfeld C.R., et al. Prenatal care evaluation and cohort analyses. Pediatrics 85 (1990) 195-204
163. Maloni J.A., and Damato E.G. Reducing the risk for preterm birth: evidence and implications for neonatal nurses. Adv Neonatal Care 4 (2004) 166-174
164. Olds D.L., Henderson Jr. C.R., Tatelbaum R., et al. Improving the life-course development of socially disadvantaged mothers: a randomized trial of nurse home visitation. Am J Public Health 78 (1988) 1436-1445
165. Olds D.L., Eckenrode J., Henderson Jr. C.R., et al. Long-term effects of home visitation on maternal life course and child abuse and neglect. Fifteen-year follow-up of a randomized trial. JAMA 278 (1997) 637-643
166. Olds D.L., Robinson J., O'Brien R., et al. Home visiting by paraprofessionals and by nurses: a randomized, controlled trial. Pediatrics 110 (2002) 486-496
167. Olds D.L., Kitzman H., Hanks C., et al. Effects of nurse home visiting on maternal and child functioning: age-9 follow-up of a randomized trial. Pediatrics 120 (2007) e832-845
168. Dunlop A.L., Dubin C., Raynor B.D., et al. Interpregnancy primary care and social support for African-American women at risk for recurrent very-low-birthweight delivery: a pilot evaluation. Matern Child Health J 12 (2008) 461-468
169. McLaughlin F.J., Altemeier W.A., Christensen M.J., et al. Randomized trial of comprehensive prenatal care for low-income women: effect on infant birth weight. Pediatrics 89 (1992) 128-132
170. Peltoniemi O.M., Kari M.A., Tammela O., et al. Randomized trial of a single repeat dose of prenatal betamethasone treatment in imminent preterm birth. Pediatrics 119 (2007) 290-298
171. Luke B., Marmelle M., Keith L., et al. The association between occupational factors and preterm birth: a United States nurses' study. Research Committee of the Association for Women's Health, Obstetric, and Neonatal Nurses. Am J Obstet Gynecol 173 (1995) 849-862
172. Tough S.C., Newburn-Cook C., Johnston D.W., et al. Delayed childbearing and its impact on population rate changes in lower birth weight, multiple birth, and preterm delivery. Pediatrics 109 (2002) 399-403
173. Edison R.J., Berg K., Remaley A., et al. Adverse birth outcome among mothers with low serum cholesterol. Pediatrics 120 (2007) 723-733
174. Mercer B., Milluzzi C., and Collin M. Periviable birth at 20 to 26 weeks of gestation: proximate causes, previous obstetric history and recurrence risk. Am J Obstet Gynecol 193 (2005) 1175-1180
175. Massett H.A., Greenup M., Ryan C.E., et al. Public perceptions about prematurity: a national survey. Am J Prev Med 24 (2003) 120-127
176. ACOG Committee Opinion #324. Perinatal risks associated with assisted reproductive technology. Obstet Gynecol 106 (2005) 1143-1146
177. In: Behrman R.E., and Stith Butler A. (Eds). Committee on understanding premature birth and assuring healthy outcomes (2006), National Academies Press, Washington, DC
178. Min J.K., Claman P., Hughes E., et al. Guidelines for the number of embryos to transfer following in vitro fertilization. J Obstet Gynaecol Can 28 (2006) 799-813
179. ACOG Committee Opinion # 313. The importance of preconception care in the continuum of women's health care. Obstet Gynecol 106 (2005) 665-666
180. Bukowski R., Malone F.D., Porter F., et al. Preconceptional folate prevents preterm delivery. Am J Obstet Gynecol 197 (2007) S3 [abstract], 2008 Society for Maternal Fetal Medicine
181. Bakketeig L.S., and Hoffman H.J. Epidemiology of preterm birth: results from a longitudinal study in Norway. In: Elder M.G., and Hendricks C.H. (Eds). Preterm labor (1981), Butterworths, London 17
182. Adams M.M., Elam-Evans L.D., Wilson H.G., et al. Rates of and factors associated with recurrence of preterm delivery. JAMA 283 (2000) 1591-1596
183. Goldenberg R.L., Andrews W.W., Faye-Peterson O., et al. The Alabama preterm birth project: placental histology in recurrent spontaneous and indicated preterm birth. Am J Obstet Gynecol 195 (2006) 792-796
184. Ananth C.V., Getahun D., Peltier M.R., et al. Recurrence of spontaneous versus medically indicated preterm birth. Am J Obstet Gynecol 195 (2006) 643-650
185. Haas J.S., Fuentes-Afflick E., Stewart A.L., et al. Pre-pregnancy health status and the risk of preterm delivery. Arch Pediatr Adolesc Med 159 (2005) 58-63
186. Roberts J.M., and for the NICHD MFMU Network. A randomized controlled trial of antioxidant vitamins to prevent serious complications associated with pregnancy related hypertension in low risk nulliparous women. Am J Obstet Gynecol 199 (2008) S4 [abstract], 2009 Society for Maternal Fetal Medicine
187. Biermann J., Dunlop A.L., Brady C., et al. Promising practices in preconception care for women at risk for poor health and pregnancy outcomes. Matern Child Health J 10 (2006) S21-S28
188. Harper M. Randomized controlled trial of omega-3 fatty acid supplementation for recurrent preterm birth prevention. [abstract]. Presented at the International Society for the Study of Fatty Acids and Lipids (2008)
189. Offenbacher S., Beck J., Jared H., et al. Maternal oral therapy to reduce obstetric risk (MOTOR): a report of a multicentered periodontal therapy randomized controlled trial on rate of preterm delivery. [abstract]. Am J Obstet Gynecol 199 (2008) 52
190. Macones G., Jeffcoat M., Parry S., et al. Screening and treating periodontal disease in pregnancy does not reduce the incidence of preterm birth: results from the PIPS Study. [abstract]. Am J Obstet Gynecol 199 (2008) 53
191. Smaill F. Antibiotics for asymptomatic bacteruria in pregnancy. Cochrane Database Syst Rev 2 (2001) CD000490
192. Hauth J.C., Goldenberg R.L., Andrews W.W., et al. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N Engl J Med 333 (1995) 1732-1736
193. Gichangi P.B., Ndinya-Achola J.O., Ombete J., et al. Antimicrobial prophylaxis in pregnancy: a randomized, placebo-controlled trial with cefetamet-pivoxil in pregnant women with a poor obstetric history. Am J Obstet Gynecol 177 (1997) 680-684
194. Vermeulen G.M., and Bruinse H.W. Prophylactic administration of clindamycin 2% vaginal cream to reduce the incidence of spontaneous preterm birth in women with an increased recurrence risk: a randomised placebo-controlled double-blind trial. Br J Obstet Gynaecol 106 (1999) 652-657
195. Joesoef M.R., Hillier S.L., Wiknjosastro G., et al. Intravaginal clindamycin treatment for bacterial vaginosis: effects on preterm delivery and low birth weight. Am J Obstet Gynecol 173 (1995) 1527-1531
196. McDonald H.M., O'Loughlin J.A., Vigneswaran R., et al. Impact of metronidazole therapy on preterm birth in women with bacterial vaginosis flora (Gardnerella vaginalis): a randomized, placebo controlled trial. BJOG 104 (1997) 1391-1397
197. Carey J.C., Klebanoff M., and Hauth J.C. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 342 (2000) 534-540
198. Rosenstein I.J., Morgan D.J., Lamont R.F., et al. Effect of intravaginal clindamycin cream on pregnancy outcome and on abnormal vaginal microbial flora of pregnant women. Infect Dis Obstet Gynecol 8 (2000) 158-165
199. Kurkinen-Raty M., Vuopala S., Koskela M., et al. A randomized controlled trial of vaginal clindamycin for early pregnancy bacterial vaginosis. BJOG 107 (2000) 1427-1432
200. Kekki M., Kurki T., Pelkonen J., et al. Vaginal clindamycin in preventing preterm birth and peripartal infections in asymptomatic women with bacterial vaginosis. Obstet Gynecol 97 (2001) 643
201. Ugwumadu A., Manyonda I., Reid F., et al. Effect of early oral clindamycin on late miscarriage and preterm delivery in asymptomatic women with abnormal vaginal flora and bacterial vaginosis: a randomised controlled trial. Lancet 361 (2003) 983-988
202. Lamont R.F., Duncan S.L.B., Mandal D., et al. Intravaginal clindamycin to reduce preterm birth in women with abnormal genital tract flora. Obstet Gynecol 101 (2003) 516-522
203. Kiss H., Petricevic L., and Husslein P. Prospective randomised controlled trial of an infection screening programme to reduce the rate of preterm delivery. BMJ 329 (2004) 371-375
204. Larsson P.G., Fahraeus L., Carlsson B., et al. Late miscarriage and preterm birth after treatment with clindamycin: a randomised consent design study according to Zelen. BJOG 113 (2006) 629-637
205. American College of Obstetricians and Gynecologists. Assessment of risk factors for preterm birth. ACOG Practice Bulletin number 31. Obstet Gynecol 98 (2001) 709-716
206. Rouse D.J., Caritis S.N., Peaceman A.M., et al. A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. N Engl J Med 357 (2007) 454-461
207. Northen A.T., Norman G.S., Anderson K., et al. Follow-up of children exposed in utero to 17 alpha-hydroxyprogesterone caproate compared with placebo. Obstet Gynecol 110 (2007) 865-872
208. Meis P.J., and Society for Maternal-Fetal Medicine. 17 Hydroxyprogesterone for the prevention of preterm delivery. Obstet Gynecol 105 (2005) 1128-1135
209. Christian M.S., Brent R.L., and Calda P. Embryo-fetal toxicity signals for 17alpha-hydroxyprogesterone caproate in high-risk pregnancies: a review of the non-clinical literature for embryo-fetal toxicity with progestins. J Matern Fetal Neonatal Med 20 (2007) 89-112
210. Petrini J.R., Callaghan W.M., and Klebanoff M. Estimated effect of 17 alpha hydroxy-progesterone caproate on preterm birth in the United States. Obstet Gynecol 105 (2005) 267-272
211. Bailit J.L., and Votruba M.E. Medical cost savings associated with 17 alpha-hydroxyprogesterone caproate. Am J Obstet Gynecol 196 (2007) 219 e1-7
212. Armstrong J. 17 Progesterone for preterm birth prevention: a potential $2 billion opportunity. Am J Obstet Gynecol 196 (2007) 194-195
213. Shapiro-Mendoza C.K., Tomashek K.M., Kotelchuk M., et al. Effect of late-preterm birth and maternal medical conditions on newborn morbidity risk. Pediatrics 121 (2008) e223-e232
214. Sibai B.M., Mabie W.C., Shamsa F., et al. A comparison of no medication versus methyldopa or labetalol in chronic hypertension during pregnancy. Am J Obstet Gynecol 162 (1990) 960-966
215. Redman C.W. Controlled trials of antihypertensive drugs in pregnancy. Am J Kidney Dis 17 (1991) 149-153
216. Chang J., Elam-Evans L.D., Berg C.J., et al. Pregnancy-related mortality surveillance-United States, 1991-1999. MMWR Surveill Summ 52 (2003) 1-8
217. US Department of Health and Human Services. Healthy people. Available at: http://www.healthypeople.gov/.
218. Antepartum fetal surveillance. ACOG Practice Bulletin number 9. American College of Obstetricians and Gynecologists (1999)
219. Reid R., Ivey K.J., Rencoret R.H., et al. Fetal complications of obstetric cholestasis. BMJ 1 (1976) 870-872
220. Al Inizi S., Gupta R., and Gale A. Fetal tachyarrhythmia with atrial flutter in obstetric cholestasis. Int J Gynaecol Obstet 93 (2006) 53-54
221. Mathews T.J., and MacDorman M.F. Infant mortality from the 2005 period linked birth/infant death data set. Natl Vital Stat Rep 57 (2008)
222. Ananth C.V., Gyamfi C., and Jain L. Characterizing risk profiles of infants who are delivered at late preterm gestations: does it matter?. Am J Obstet Gynecol 199 (2008) 329-331
223. Ananth C.V., Joseph K.S., Oyelese Y., et al. Trends in preterm birth and perinatal mortality among singletons: United States, 1989 through 2000. Obstet Gynecol 105 (2005) 1084-1091